These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 31333603)

  • 21. Nucleic acid aptamer application in diagnosis and therapy of colorectal cancer based on cell-SELEX technology.
    Chen C; Zhou S; Cai Y; Tang F
    NPJ Precis Oncol; 2017; 1(1):37. PubMed ID: 29872716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aptamers in diagnostics and treatment of viral infections.
    Wandtke T; Woźniak J; Kopiński P
    Viruses; 2015 Feb; 7(2):751-80. PubMed ID: 25690797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aptamers against pathogenic microorganisms.
    Davydova A; Vorobjeva M; Pyshnyi D; Altman S; Vlassov V; Venyaminova A
    Crit Rev Microbiol; 2016 Nov; 42(6):847-65. PubMed ID: 26258445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advancements in complex target systematic evolution of ligands by exponential enrichment].
    Wu Z; Xue S; Yang Y
    Se Pu; 2018 Oct; 36(10):947-951. PubMed ID: 30378352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of DNA aptamers that bind to influenza A viruses with high affinity and broad subtype specificity.
    Shiratori I; Akitomi J; Boltz DA; Horii K; Furuichi M; Waga I
    Biochem Biophys Res Commun; 2014 Jan; 443(1):37-41. PubMed ID: 24269231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aptamer-Based Technologies in Foodborne Pathogen Detection.
    Teng J; Yuan F; Ye Y; Zheng L; Yao L; Xue F; Chen W; Li B
    Front Microbiol; 2016; 7():1426. PubMed ID: 27672383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses.
    González VM; Martín ME; Fernández G; García-Sacristán A
    Pharmaceuticals (Basel); 2016 Dec; 9(4):. PubMed ID: 27999271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection and characterization of DNA aptamers for use in detection of avian influenza virus H5N1.
    Wang R; Zhao J; Jiang T; Kwon YM; Lu H; Jiao P; Liao M; Li Y
    J Virol Methods; 2013 May; 189(2):362-9. PubMed ID: 23523887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of aptamers for targeted therapeutics.
    Ray P; Viles KD; Soule EE; Woodruff RS
    Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):255-71. PubMed ID: 23563807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of ssDNA aptamers that inhibit rabies virus.
    Liang HR; Hu GQ; Zhang T; Yang YJ; Zhao LL; Qi YL; Wang HL; Gao YW; Yang ST; Xia XZ
    Int Immunopharmacol; 2012 Nov; 14(3):341-7. PubMed ID: 22771543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of ssDNA aptamers specifically directed against Trachinotus ovatus NNV (GTONNV)-infected cells with antiviral activities.
    Yu Q; Liu M; Wei S; Wu S; Xiao H; Qin X; Su H; Li P
    J Gen Virol; 2019 Mar; 100(3):380-391. PubMed ID: 30698517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aptamers in Therapeutics.
    Parashar A
    J Clin Diagn Res; 2016 Jun; 10(6):BE01-6. PubMed ID: 27504277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aptamer Selection for Detecting Molecular Target Using Cell-SELEX (Systematic Evolution of Ligands by Exponential Enrichment) Technology.
    Stewart KD; Tan W; Park JY
    Methods Mol Biol; 2019; 2054():223-241. PubMed ID: 31482459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in aptamer selection methods and applications.
    Yüce M; Ullah N; Budak H
    Analyst; 2015 Aug; 140(16):5379-99. PubMed ID: 26114391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Replacing antibodies with aptamers in lateral flow immunoassay.
    Chen A; Yang S
    Biosens Bioelectron; 2015 Sep; 71():230-242. PubMed ID: 25912679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
    Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oligonucleotide aptamers for glioma targeting: an update.
    Camorani S; Cerchia L
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):126-37. PubMed ID: 25924917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aptamer-based 'point-of-care testing'.
    Gopinath SC; Lakshmipriya T; Chen Y; Phang WM; Hashim U
    Biotechnol Adv; 2016; 34(3):198-208. PubMed ID: 26876017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA aptamers for the detection of Haemophilus influenzae type b by cell SELEX.
    Bitaraf FS; Rasooli I; Mousavi Gargari SL
    Eur J Clin Microbiol Infect Dis; 2016 Mar; 35(3):503-10. PubMed ID: 26768582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.